Thompson F N, Page R D, Cook C B, Caudle A B
Department of Physiology & Pharmacology, College of Veterinary Medicine, University of Georgia, Athens 30602.
Vet Res Commun. 1987;11(6):503-7. doi: 10.1007/BF00396367.
The stable metabolite of prostaglandin F2 alpha,15 keto-13,14-dihydroprostaglandin F2 alpha (PGFM), was measured from peripheral blood samples collected at specified intervals postpartum from 7 normal dairy cows and 4 cows with apparent endometritis. Plasma PFGM levels were significantly (P less than .05) elevated for the first 5 days postpartum in the cows with endometritis (ranging from 4.0 to 5.0 ng/ml) compared to the controls (approximately 1.0 ng/ml). Beyond 5 days postpartum, plasma PGFM levels were not significantly different and decreased to approximately 0.4 ng/ml by day 13 in both groups. Time to uterine involution was not different between groups (less than 30 days). Therefore, uterine infections in cows during the puerperium was associated with elevated circulating PGFM levels. These findings and the observation that PGF2 alpha is not uterotonic in the puerperal cow do not suggest a therapeutic use of PGF2 alpha in order to evacuate the uterus.
从7头正常奶牛和4头患有明显子宫内膜炎的奶牛产后特定时间采集的外周血样本中,检测前列腺素F2α的稳定代谢产物15-酮-13,14-二氢前列腺素F2α(PGFM)。与对照组(约1.0 ng/ml)相比,患有子宫内膜炎的奶牛产后前5天血浆PGFM水平显著升高(P<0.05)(范围为4.0至5.0 ng/ml)。产后5天之后,两组血浆PGFM水平无显著差异,到第13天两组均降至约0.4 ng/ml。两组子宫复旧时间无差异(小于30天)。因此,奶牛产褥期子宫感染与循环中PGFM水平升高有关。这些发现以及PGF2α对产后奶牛无子宫收缩作用的观察结果表明,PGF2α不适合用于治疗性排空子宫。